WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma

Histopathology

Volumn 44, Issue 2, 2004, Pages 109-115

  Al Hussaini, M ^a   Stockman, A ^a   Foster, H ^a   McCluggage, W G ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

Endometrioid carcinoma; Immunohistochemistry; Ovary; Primary peritoneal serous carcinoma; Serous borderline tumour; Serous carcinoma; Uterine serous carcinoma; WT 1

Indexed keywords

WT1 PROTEIN;

ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; ENDOMETRIOID CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; OVARY CARCINOMA; PRIORITY JOURNAL; SCORING SYSTEM; SEROSA; TISSUE DIFFERENTIATION; UTERUS CARCINOMA;

CARCINOMA, ENDOMETRIOID; CYSTADENOCARCINOMA, SEROUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS; WT1 PROTEINS;

FALLOPIA;

EID: 1542270080     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2004.01787.x     Document Type: Article

References (29)

1. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R. Uterine papillary serous carcinoma. A highly malignant form of endometrial adenocarcinoma. Am. J. Surg. Pathol. 1982; 6; 93-108.
2. Silva EG, Jenkins R. Serous carcinoma in endometrial polyps. Mod. Pathol. 1990; 3; 120-128.
3. Wheeler DT, Bell KA, Kurman RJ, Sherman ME. Minimal uterine serous carcinoma. Diagnosis and clinicopathologic correlation. Am. J. Surg. Pathol. 2000; 24; 797-866.
4. McCluggage WG, Sumathi VP, McManus DT. Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of five cases including two associated with tamoxifen therapy. Hum. Pathol. 2003; 34; 939-943.
5. Goldstein NS, Uzieblo A. WT-1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas. Am. J. Clin. Pathol. 2002; 117; 541-545.
6. Shimizu M, Toki T, Takagi Y, Konishi I, Fujii S. Immunohistochemical detection of the Wilm's tumor gene (WT1) in epithelial ovarian tumors. Int. J. Gynecol. Pathol. 2000; 19; 158-163.
7. Pritchard-Jones K, Hastie ND. Wilm's tumour as a paradigm for the relationship of cancer to development. Cancer Surv. 1990; 9; 555-578.
8. Pritchard-Jones K, Fleming S, Davidson D et al. The candidate Wilm's tumour gene is involved in genitourinary development. Nature 1990; 346; 194-197.
9. Charles AK, Mall S, Watson J, Berry PJ. Expression of the Wilm's tumour gene WT1 in the developing human and in paediatric renal tumours: an immunohistochemical study. Mod. Pathol. 1997; 50; 138-144.
10. Amin KM, Litzky LA, Smythe WR et al. Wilms' tumor 1 susceptibility (WT-1) gene products are selectively expressed in malignant mesothelioma. Am. J. Pathol. 1995; 146; 344-356.
11. Oates J, Edward C. HBME-1, MOC-31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma. Histopathology 2000; 36; 341-347.
12. Charles AK, Moore IE, Berry PJ. Immunohistochemical detection of the Wilm's tumour gene WT1 in desmoplastic small round cell tumour. Histopathology 1997; 30; 312-314.
13. Ordonez NG. Desmoplastic small round cell tumour II: an ultrastructural and immunohistochemical study with emphasis on new immunohistochemical markers. Am. J. Surg. Pathol. 1998; 22; 1314-1327.
14. Silberstein GB, van Horn K, Strickland P, Roberts CT, Daniel CW. Altered expression of the WT1 Wilm's tumor suppressor gene in human breast cancer. Proc. Natl Acad. Sci. USA 1997; 94; 8132-8137.
15. Goldstein NS, Bassi D, Uzieblo A. WT-1 is an integral component of an antibody panel to distinguish pancreatobiliary and some ovarian epithelial neoplasms. Am. J. Clin. Pathol. 2001; 116; 246-252.
16. Lee BH, Hecht JL, Pinkus JL, Pinkus GS. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids. Am. J. Clin. Pathol. 2002; 117; 745-750.
17. Schorge JO, Miller YB, Qi LJ, Muto MG, Welch WR, Berkowitz RS. Genetic alterations of the WT-1 gene in papillary serous carcinoma of the peritoneum. Gynecol. Oncol. 2000; 76; 369-372.
18. Ambros RA, Sherman ME, Zahn CM, Bitterman P, Kurman RJ. Endometrial intraepithelial carcinoma: distinctive lesion specifically associated with tumors displaying serous differentiation. Hum. Pathol. 1995; 26; 1260-1267.
19. Spiegel GW. Endometrial carcinoma in situ in postmenopausal women. Am. J. Surg. Pathol. 1995; 19; 417-432.
20. Tashiro H, Isacson C, Levine R, Kurman RJ, Cho KR, Hedrick L. p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am. J. Pathol. 1997; 150; 170-185.
21. Baergen RN, Warren CP, Isacson C, Hedrick Ellenson L. Early uterine serous carcinoma: clonal origin of extrauterine disease. Int. J. Gynecol. Pathol. 2001; 20; 214-219.
22. Goff BA, de la Cuesta RS, Muntz HG et al. Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol. Oncol. 1996; 60; 412-417.
23. Feeley KM, Wells M. Precursor lesions of ovarian epithelial malignancy. Histopathology 2001; 38; 87-95.
24. Seldman JP, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am. J. Surg. Pathol. 1996; 20; 1331-1345.
25. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low grade carcinoma related to serous borderline tumors. Am. J. Surg. Pathol. 1996; 20; 1319-1330.
26. Prat J, De Nictolis M. Serous borderline tumors of the ovary: a long-term follow up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am. J. Surg. Pathol. 2002; 26; 1111-1128.
27. Eichhorn JH, Bell DA, Young RH, Scully RE. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with cases without these patterns. Am. J. Surg. Pathol. 1999; 23; 397-109.
28. Staebler A, Heselmeyer-Haddad K, Bell K et al. Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas. Hum. Pathol. 2002; 33; 47-59.
29. Singer G, Kurman RJ, Chang HW, Cho SK, Shih IEM. Diverse tumorigenic pathways in ovarian serous carcinoma. Am. J. Pathol. 2002; 160; 1223-1228.